Weekly Life Science News Round Up: 2nd – 6th May
A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Devices sectors from 2nd – 6th May.
Gilead Sciences and Dragonfly Therapeutics announce a collaboration designed to advance a number of Dragonfly’s novel natural killer (NK) cell engager-based immunotherapies for oncology and inflammation indications.
Global biopharmaceutical services leader, CATO SMS, today unveiled its new name, Allucent with bold branding to emphasize the company’s spotlight on serving the specialized needs of small and mid-sized biotech companies.
Catalyst Clinical Research announces the strategic acquisition of Aptus Clinical to expand the geographic reach of the two companies, and to enhance patient access to advanced, life-changing therapies.
AVDANZ PHARMA has signed an agreement with Intercept Pharmaceuticals to acquire the majority of Intercept’s subsidiaries and operations in Europe, Canada, and all other markets outside of the U.S.
Nicoya completes acquisition of LSK Technologies, expanding digital platform into molecular testing
Nicoya Lifesciences announces the acquisition of LSK Technologies, a University of Toronto startup decentralizing laboratory testing with their high-throughput lab-in-a-box platform.
The Orano Group announces the acquisition by Orano Projects of INEVO, an engineering firm specialized in process engineering and the optimization of industrial performance.
Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership
Medartis Holding AG announces that is has completed the acquisition of Nextremity Solutions Inc., a strategic commercialisation organisation located in Warsaw, USA.
Elligo launches European operations to enable research through healthcare
Elligo Health Research®, the ultimate healthcare-enabling research organization, announces a new collaboration with WHYZE Health, a digital platform that strives to unify research, healthcare, and patient data.
Matica Bio opens new cell and gene therapy GMP facility in Texas
Matica Biotechnology, Inc. announces the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.
Novotech acquires US CRO NCGS, expands global expertise
Novotech has acquired US CRO NCGS as part of its expansion program, and can now offer its biotech clients clinical services in the US to support later phase global studies.
Applications open for SmiLe’s international Biotech program with BioM and Merck
Applications are now open for Biotech Bootcamp, SmiLe’s new, international training program for future biotech entrepreneurs which is fun in full partnership with one of Europe’s leading biotechnology clusters, BioM in Germany and sponsored by Merck.
The robotic cell therapy manufacturing Consortium founded by Multiply Labs, with initial participation from UCSF and Cytiva, announces that Thermo Fisher Scientific and Charles River Laboratories, Inc. are joining.
P360 launches ZING Engagement Suite to help pharma sales teams improve HCP engagement
P360 announces the launch of its ZING Engagement Suite, which helps pharmaceutical sales teams seamlessly engage with today’s hard-to-reach healthcare professionals (HCP) at scale.
NextGen Healthcare announces a partnership with Circuit Clinical to bring clinical trial access to patients of Federally Qualified Health Centers (FQHCs) through over 14,000 providers that utilize NextGen Healthcare solutions.
Neuraxpharm pursues growth strategy for business in Switzerland
Neuraxpham Group ignites the next level of their business in Switzerland to leverage the full potential of the important pharmaceutical market.
-
See more of the latest Life Science news on PharmiWeb.com and PharmiWeb.Jobs.
